Evidence map›Paper›PMID 36690289›Full record

Trial reportAmerican journal of ophthalmology2023

Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline Results and Costs of a Cluster-Randomized Trial.

Lisa A Hark, Jason D Horowitz, Prakash Gorroochurn, Lisa Park, Qing Wang, Daniel F Diamond, Noga Harizman, James D Auran, Stefania C Maruri, Desiree R Henriquez and 11 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04271709 (The Manhattan Vision Screening and Follow-Up Study), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04271709 naactive not recruitingnot on this map

The Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

TypeinterventionalSponsorColumbia UniversityRan2019 to 2026Enrolled749ConditionsGlaucoma, Vision Impairment and Blindness, Cataract, Diabetic RetinopathyArmsEnhanced Intervention Using Patient Navigators, Usual Care
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Manhattan Vision Screening and Follow-Up Study: (NYC-SIGHT)Tele-Retinal Image Findings and Importance of Photography.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024
    Trial
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Lisa A HarkFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA; Edward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA. Electronic address: lah112@cumc.columbia.edu.
Jason D HorowitzFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA; Edward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
Prakash GorroochurnDepartment of Biostatistics (P.G.), Columbia University Mailman School of Public Health, New York, New York, USA.
Lisa ParkFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA; Edward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
Qing WangFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA; Edward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
Daniel F DiamondFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA; Edward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
Noga HarizmanFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA; Edward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
James D AuranFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA; Edward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
Stefania C MaruriEdward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
Desiree R HenriquezEdward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
Jailine CarrionEdward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
Remy S Manzi MuhireEdward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
Yocheved S KreschEdward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA; Kresge Eye Institute (Y.S.K.), Wayne State University School of Medicine, Detroit, Michigan, USA.
Laura T PizziCenter for Health Outcomes, Policy, and Economics (L.T.P.), Rutgers University Ernest Mario School of Pharmacy, Piscataway, New Jersey, USA.
Eric JutkowitzDepartment of Health Services, Policy & Practice (E.J.), Brown University School of Public Health, Providence, Rhode Island, USA.
Saloni SapruWestat Public Health and Epidemiology Practice (S.S.), Rockville, Maryland, USA.
Tarun SharmaFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA; Edward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
C Gustavo De MoraesFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA; Edward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
David S FriedmanMassachusetts Eye and Ear Infirmary (D.S.F.), Harvard Medical School, Glaucoma Service, Boston, Massachusetts, USA.
Jeffrey M LiebmannFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA.
George A CioffiFrom the Department of Ophthalmology (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., T.S., C.G.D., J.M.L., G.A.C.), Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA; Edward S. Harkness Eye Institute (L.A.H., J.D.H., L.P., Q.W., D.F.D., N.H., J.D.A., S.C.M., D.R.H., J.C., R.S.M.M., Y.S.K., T.S., C.G.D., J.M.L., G.A.C.), Columbia University Irving Medical Center, New York, New York, USA.
Harley-Davidson (United States) · USColumbia University · USBrown University · USMassachusetts Eye and Ear Infirmary · USRutgers, The State University of New Jersey · USWayne State University · USWestat (United States) · US

Funding

Manhattan Vision Screening and Follow-Up Study in Vulnerable PopulationsU01DP006436 · DP · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HARK, LISA A. · 2019 to 2023
$3.5M
Coordinating Center for Community-Based Interventions with Vulnerable PopulationsU01DP006435 · DP · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HARK, LISA A., PRICE, SIMANI · 2019 to 2023
$1.2M
NCCDPHP CDC HHS U01 DP006435NCCDPHP CDC HHS U01 DP006436
6 · The paper itself

Abstract

purposeTo describe the 15-month baseline results and costs of the Manhattan Vision Screening and Follow-up Study, which aims to investigate whether innovative community-based eye health screening can improve early detection and management of glaucoma and other eye diseases among high-risk populations.

designFive-year prospective, cluster-randomized controlled trial.

methodsIndividuals aged 40+ years were recruited from public housing buildings in New York City for an eye health screening (visual acuity (VA) with correction, intraocular pressure measurements (IOP), and fundus photography). Participants with VA 20/40 or worse, IOP 23-29 mm Hg, or an unreadable fundus image failed the screening and were scheduled for an optometric examination at the same location; those with an abnormal image were referred to ophthalmology. A cost analysis was conducted alongside the study.

resultsA total of 708 participants were screened; mean age 68.6±11.9 years, female (65.1%), African American (51.8%) and Hispanic (42%). 78.4% (n = 555) failed the eye health screening; 35% (n= 250) had an abnormal image and were also referred to ophthalmology. 308 participants attended the optometric exam; 218 were referred to ophthalmology. Overall, 66.1% were referred to ophthalmology. The cost per participant to deliver the eye health screening and optometric examination was $180.88. The cost per case of eye disease detected was $273.64.

conclusionsThis innovative study in public housing developments targeted high-risk populations, provided access to eye-care, and improved early detection of ocular diseases in New York City. The study has identified strategies to overcoming barriers to eye care to reduce eye health disparities.

Indexed as

GlaucomaVision ScreeningAgedAged, 80 and overFemaleFollow-Up StudiesHumansIntraocular PressureMiddle AgedProspective Studies

Identifiers

PMID36690289
PMCPMC10257220
OpenAlexW4317569194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.